Clinical Trial Update: Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer [Phase 1]

View source ↗

Summary

This document reports an ongoing Phase 1 clinical trial evaluating the combination of alpelisib and sacituzumab govitecan for breast cancer, with the study curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Piqray (alpelisib)
• TRODELVY (sacituzumab govitecan)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING